Research Progress of Saliva in Diagnosis of Geriatric Diseases

doi:10.13701/j.cnki.kqyxyj.2019.03.007

Abstract

Abstract: Salivary diagnostics is an emerging field in the diagnosis of diseases. Saliva reflects the physiologic state of body, including emotional, endocrinal, nutritional, and metabolic variations. The collection of samples is noninvasive, safe and inexpensive, thus it has potential advantages in the diagnosis and treatment of diseases in the elderly. This article focuses on the application of saliva in oral and systemic diseases in geriatric population. It has a huge potential and will be converted into point of chair testing (POCT), making contributions for the advent of the era of personalized medicine and promote diagnostic technology of diseases for the elderly.

Key words: Geriatric population, Oral disease, Systemic diseases, Saliva diagnostics, Biomarker

LIAN Qi-si, Wu Hong-kun. Research Progress of Saliva in Diagnosis of Geriatric Diseases[J]. Journal of Oral Science Research, 2019, 35(3): 224-226.

References

[1] Khurshid Z, Zohaib S, Najeeb S, et al. Advances of proteomic sciences in dentistry [J]. Int J Mol Sci, 2016, 17(5). pii: E728.
[2] Farah R, Haraty H, Salame Z, et al. Salivary biomarkers for the diagnosis and monitoring of neurological diseases [J]. Biomed J, 2018, 41(2):63-87.
[3] Gudiseva HV, Hansen M, Gutierrez L, et al. Saliva DNA quality and genotyping efficiency in a predominantly elderly population [J]. BMC Med Genomics, 2016, 9:17.
[4] Kishore M, Panat SR, Choudhary A, et al. Oral diagnostics: an integral component to geriatric health care [J]. Aging Male, 2013, 16(4):159-163.
[5] 杨会肖,吕胡玲,陈慧姗,等.老年根龋患者唾液菌群多样性初步分析[J].中华老年口腔医学杂志,2018,16(5):262-267.
[6] Saucedo NM, Gao Y, Pham T, et al. Lectin- and saccharide-functionalized nano-chemiresistor arrays for detection and identification of pathogenic bacteria infection [J]. Biosensors, 2018, 8(3):63.
[7] Tominaga Y, Usui K, Hirata A, et al. Applications of a novel biodetection system to saliva using protein fingerprints with data processing [J]. Bioorg Med Chem, 2018, 26(12):3210-3216.
[8] Alassiri S, Parnanen P, Rathnayake N, et al. The ability of quantitative, specific, and sensitive point-of-care/chair-side oral fluid immunotests for aMMP-8 to detect periodontal and peri-implant diseases [J]. Dis Markers, 2018, 2018:1306396.
[9] Talungchit S, Buajeeb W, Lerdtripop C, et al. Putative salivary protein biomarkers for the diagnosis of oral lichen planus: a case-control study [J]. BMC Oral Health, 2018, 18(1):42.
[10] Mehdipour M, Shahidi M, Manifar S,et al. Diagnostic and prognostic relevance of salivary microRNA-21, -125a, -31 and -200a levels in patients with oral lichen planus-a short report [J]. Cell Oncol (Dordr), 2018, 41(3):329-334.
[11] Azuma N, Katada Y, Sano H. Deterioration in saliva quality in patients with Sjogren's syndrome: impact of decrease in salivary epidermal growth factor on the severity of intraoral manifestations [J]. Inflamm Regen, 2018, 38:6.
[12] Tvarijonaviciute A, Zamora C, Martinez-Subiela S, et al.Salivary adiponectin, but not adenosine deaminase, correlates with clinical signs in women with Sjogren's syndrome: a pilot study [J]. Clin Oral Investig, 2018 [Epub ahead of print].
[13] Lohavanichbutr P, Zhang Y, Wang P,et al. Salivary metabolite profiling distinguishes patients with oral cavity squamous cell carcinoma from normal controls [J]. PLoS One, 2018, 13(9):e0204249.
[14] Gai C, Camussi F, Broccoletti R,et al. Salivary extracellular vesicle-associated miRNAs as potential biomarkers in oral squamous cell carcinoma [J]. BMC Cancer, 2018, 18(1):439.
[15] Carnielli CM, Macedo CCS, De Rossi T,et al. Combining discovery and targeted proteomics reveals a prognostic signature in oral cancer [J]. Nat Commun, 2018, 9(1):3598.
[16] Franzmann EJ, Donovan MJ. Effective early detection of oral cancer using a simple and inexpensive point of care device in oral rinses [J]. Expert Rev Mol Diagn, 2018, 18(10):837-844.
[17] Gohel V, Jones JA, Wehler CJ. Salivary biomarkers and cardiovascular disease: a systematic review [J]. Clin Chem Lab Med, 2018, 56(9):1432-1442.
[18] Thul S, Labat C, Temmar M,et al. Low salivary resolvin D1 to leukotriene B4 ratio predicts carotid intima media thickness: A novel biomarker of non-resolving vascular inflammation [J]. Eur J Prev Cardiol, 2017, 24(9):903-906.
[19] Tripoliti EE, Papadopoulos TG, Karanasiou GS,et al. A computational approach for the estimation of heart failure patients status using saliva biomarkers [J]. Conf Proc IEEE Eng Med Biol Soc, 2017, 2017:3648-3651.
[20] Yilmaz A, Geddes T, Han B, et al. Diagnostic biomarkers of Alzheimer's disease as identified in saliva using ¹H NMR-based metabolomics [J]. J Alzheimers Dis, 2017, 58(2):355-359.
[21] Carro E, Bartolome F, Bermejo-Pareja F,et al. Early diagnosis of mild cognitive impairment and Alzheimer's disease based on salivary lactoferrin [J]. Alzheimers Dement (Amst), 2017, 8:131-138.
[22] Lee M, Guo JP, Kennedy K,et al. A method for diagnosing Alzheimer's disease based on salivary amyloid-beta protein 42 levels [J]. J Alzheimers Dis, 2017, 55(3):1175-1182.
[23] Srinivasan M, Meadows ML, Maxwell L. Assessment of salivary adipokines resistin, visfatin, and ghrelin as type 2 diabetes mellitus biomarkers [J]. Biochem Res Int, 2018, 2018:7463796.
[24] Zhang Y, Sun J, Li F, et al. Salivary extracellular RNA biomarkers for insulin resistance detection in hispanics [J]. Diabetes Res Clin Pract, 2017, 132:85-94.
[25] Jia Y, Sun H, Li X, et al. Paper-based graphene oxide biosensor coupled with smartphone for the quantification of glucose in oral fluid [J]. Biomed Microdevices, 2018, 20(4):89.
[26] Sun Y, Huo C, Qiao Z, et al. Comparative proteomic analysis of exosomes and microvesicles in human saliva for lung cancer [J]. J Proteome Res, 2018, 17(3):1101-1107.
[27] Piroozmand A, Soltani B, Razavizadeh M, et al. Comparison of the serum and salivary antibodies to detect gastric Helicobacter pylori infection in Kashan (Iran) [J]. Electron Physician, 2017, 9(12):6129-6134.
[28] Sazanov AA, Kiselyova EV, Zakharenko AA, et al. Plasma and saliva miR-21 expression in colorectal cancer patients [J]. J Appl Genet, 2017, 58(2):231-237.